Media Centre

Featured Media Release

28 Aug 2013 - Changes to Panadol® Pack Sizes

GlaxoSmithKline (GSK) is changing the number of tablets in the Panadol® 24 packs from 24 to 20 following a decision by the Therapeutic Goods Administration (TGA) to limit the maximum pack size of all paracetamol containing products sold in Australian grocery stores from 1 September 2013.


Media Releases

Twice-yearly osteoporosis treatment Prolia® (denosumab) available on the PBS for postmenopausal women with osteoporosis1

Australian women with postmenopausal osteoporosis – a chronic bone disease that weakens bones and makes them more likely to fracture – now have access to another treatment option as Prolia® (denosumab) is made available on the Pharmaceutical...



Q. Puzzled about vaccination? A.

A new website,, has been launched to provide all Australians with simple, easy to understand information about vaccine-preventable diseases at the time of life when it is most relevant to them.



Sydney manufacturing operations to change

GlaxoSmithKline (GSK) Australia announced today that the manufacture of toothpaste products will cease in Australia, Sydney by December 2011.



GSK Australia Avandia Update

GlaxoSmithKline (GSK) continues to believe that Avandia is an important treatment option for patients with type 2 diabetes, and is not aware of any legal proceedings having been initiated in Australia in respect of Avandia.



Avandia (rosiglitazone maleate) - Australian Update

Following a review of Avandia® (rosiglitazone maleate) by the European Medicines Agency (EMA) and the US Food and Drug Administration], each agency has today informed GlaxoSmithKline (GSK) of their individual regulatory decisions and resulting...



Avandia (rosiglitazone maleate): GSK Australia spokesperson available post FDA Advisory Group Recommendation.

GlaxoSmithKline (GSK) Australia Medical Director, Dr Camilla Chong will be available to speak with Australian journalists about the outcome of the U.S. Food and Drug Administration (FDA) Advisory Committee recommendation in relation to the...



ViiV Healthcare Lauched in Australia

New specialist HIV company dedicated to delivering advances in HIV treatment and care



GlaxoSmithKline Completes Acquisition of Stiefel

GlaxoSmithKline plc (GSK) announced that it has completed its acquisition of Stiefel


< 4 5 6 7 8 9 10 11 12 13 14